to
Watch a rebroadcast of this virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease.
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
Calendar of Events
S SunM MonT TueW WedT ThuF FriS Sat0 events,0 events,3 events,
to
Watch a rebroadcast of this virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease.
to
Watch a rebroadcast of this virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease.
0 events,0 events,0 events,0 events,0 events,0 events,0 events,2 events,to
Join us for part 2 of this informative international webinar where Professor Andrew Mallett, nephrologist and clinical researcher (Australia), and Dr Hila Rasouly, research scientist and genetic counselor (USA), discuss clinical genomics and its applications in kidney disease, including genetic testing for diagnosis and prognosis and the question of determining which patients to test, barriers to access, global differences across healthcare landscapes, and implications for the patient.
to
Join us for part 2 of this informative international webinar where Professor Andrew Mallett, nephrologist and clinical researcher (Australia), and Dr Hila Rasouly, research scientist and genetic counselor (USA), discuss clinical genomics and its applications in kidney disease, including genetic testing for diagnosis and prognosis and the question of determining which patients to test, barriers to access, global differences across healthcare landscapes, and implications for the patient.
0 events,0 events,0 events,0 events,0 events,0 events,2 events,to
Part 1 of this series described the fact that ADPKD is a metabolic reprogramming disease, which may benefit from novel diet strategies such as a ketogenic diet. Part 2 of this 3-part series will discuss and describe the use of a Plant-Focused Ketogenic Diet (PFKD) program for improved ADPKD outcomes.
to
Part 1 of this series described the fact that ADPKD is a metabolic reprogramming disease, which may benefit from novel diet strategies such as a ketogenic diet. Part 2 of this 3-part series will discuss and describe the use of a Plant-Focused Ketogenic Diet (PFKD) program for improved ADPKD outcomes.
0 events,0 events,0 events,0 events,0 events,0 events,0 events,2 events,to
Join us for Part II of our “Polycystic Kidney Disease Research – Past, Present, and Future” webinar where talented and emerging experts discuss efforts being made to further elucidate the molecular pathways contributing to disease and shed light on cutting edge research that may one day lead to improved options for patients living with PKD.
to
Join us for Part II of our “Polycystic Kidney Disease Research – Past, Present, and Future” webinar where talented and emerging experts discuss efforts being made to further elucidate the molecular pathways contributing to disease and shed light on cutting edge research that may one day lead to improved options for patients living with PKD.
0 events,0 events,0 events,0 events,0 events,0 events,2 events,to
In this event Dr Calvin Meaney and Dr Katie Cardone outline the role of both inpatient and outpatient clinical pharmacy services as well as discuss medication therapy challenges in managing patients with CKD.
to
In this event Dr Calvin Meaney and Dr Katie Cardone outline the role of both inpatient and outpatient clinical pharmacy services as well as discuss medication therapy challenges in managing patients with CKD.
0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,0 events,NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
